Abstract 4 Table 1

Chi square analysis; baseline features

Female Gender 19 (41%) 39 (31%) 0.2
Previous Myocardial Infarction 14 (30%) 44 (35%) 0.72
Previous Percutaneous Intervention 17 (36.5%) 40 (31.5%) 0.511
Previous CABG 7 (15%) 12 (9.5%) 0.21
History of Chronic Kidney Disease 11 (23.9%) 19 (15%) 0.13
History of Diabetes 14 (30%) 37 (29.1%) 0.86
History of Hypertension 30 (65%) 94 (74%) 0.49
Tobacco or Smoking History 18 (39%) 50 (39%) 1
History of Atrial Fibrillation (AF) 8 (17.4%) 7 (5.5%) <0.05
History of Congestive Heart Failure 10 (21.7%) 14 (11%) 0.084
History of GI Bleed 1 (2%) 2 (1.5%) 0.72
Antiplatelet Therapy 28 (60.8%) 59 (46%) 0.123
Statin Therapy 21 (45.5%) 52 (41%) 0.65
Anticoagulation Therapy 8 (17.4%) 6 (4.7%)
Beta blockade Therapy 16 (34.7%) 30 (23.6%) 0.13
Temporal change in Troponins. (Defined in as a value above the 99th percentile of the upper reference level. Additionally, evidence for a serial increase or decrease>20%‚ÄČis required. 45 (97.8%) 123 (97%) 1
EKG Changes (ST Depressions) 12 (26%) 32 (25%) 0.88
GRACE score>140 10 (21.7%) 16 (12.6%) 0.055